Cumberland Pharmaceuticals

Historical price data

Cumberland Pharmaceuticals is a specialty pharma company with a mission to improve patient care by providing branded therapeutic solutions in niche hospital and gastroenterology markets. Its core achievement is building and sustaining a portfolio of commercial products like Caldolor and Acetadote through strategic acquisition and lifecycle management. The company's strategy avoids blockbuster competition by focusing on specialized acute care areas, leveraging a targeted commercial team. As a small-cap public company, it operates with a lean model aimed at generating stable revenue from its established products while selectively pursuing pipeline expansion.

A repeatable process for pharmaceutical product development and lifecycle management, focusing on reformulation, regulatory strategy (e.g., 505(b)(2)), and commercialization of small-molecule drugs acquired or in-licensed from others.

Cumberland competes with generic manufacturers and other small specialty pharma firms in niche hospital/gastroenterology markets. Its primary competitive edge is a focused sales force, but it lacks the scale and R&D resources of larger pharmaceutical companies, making it vulnerable to pricing pressure and portfolio attrition.